Skip to main content

Dr. Guy S. Strauss, D.O.

Internal Medicine (Internal Medicine Physician)

  • Medicare participating

At a glance

Years since graduation
43
In the NPI registry since
2006
Medicare patients seen, 2024
561

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1983Medical school: New York College of Osteo Medicine of New York Institute of Technology
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Internal Medicine Physician primary
    FL license OS4706 · SC license TL1019
  • Critical Care Medicine (Internal Medicine) Physician
    FL license OS4706 · SC license TL1019

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Internal Medicine per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
561
Services billed
11,642
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Insertion of needle into vein for collection of blood sample2,465612
Established patient office or other outpatient visit, 30-39 minutes1,660572
Blood test, basic group of blood chemicals (calcium, total)1,293543
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count974486
Hemoglobin a1c level906337
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month856119
Established patient office or other outpatient visit, 20-29 minutes746364
Established patient office or other outpatient visit, 40-54 minutes701494
Magnesium level626284
Manual urinalysis test with examination using microscope, automated599468

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 11 companies reported 30 payments worth $775 in total to this clinician.

By type
Food and Beverage$585
Travel and Lodging$190

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jan 22, 2025AstraZeneca Pharmaceuticals LP
Jan 22, 2025
Travel and Lodging
travel to Boston, MA · in-kind
Company’s descriptionResearch Related Service
$109
Feb 7, 2025AstraZeneca Pharmaceuticals LP
Feb 7, 2025
Travel and Lodging
travel to Boston, MA
Company’s descriptionResearch Related Service
$48.88
Feb 7, 2025AstraZeneca Pharmaceuticals LP
Feb 7, 2025
Travel and Lodging
travel to Boston, MA
Company’s descriptionResearch Related Service
$32.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Florida →

Industry-funded research

Named as a principal investigator on 16 industry-funded studies in 2025, from 6 companies. The companies reported $2,079,389 in research payments for these studies, mostly to the institutions running them.

  • A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
    ModernaTX, Inc. · Completed · NCT06602024
  • A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age
    ModernaTX, Inc. · Completed · NCT05127434
  • A Phase IIb Randomized Double blind Placebo controlled and Open label Active Comparator Study to Evaluate the Efficacy Safety and Tolerability of AZD5004 in Adults with Type 2 Diabetes Mellitus
    AstraZeneca Pharmaceuticals LP
  • ISM2504007A--Clinical Evaluation of the i-STAT Crea, CG4+ and CG8+ Carridges using Neonatal Capillary Whole Blood Specimens with the i-STAT 1 Analyzer
    Abbott Laboratories
  • A Randomized DoubleBlind Parallel Group Multi Center Phase III Study to Assess the Efficacy of Budesonide Glycopyrronium and Formoterol Fumarate MeterednDose Inhaler Relative to Glycopyrronium and Formoterol Fumarate …
    AstraZeneca Pharmaceuticals LP
  • A phase 3 study to evaluate the efficacy immunogenicity and safety of respiratory syncytial virus rsv prefusion f subunit vaccine in adults
    Pfizer Inc.
  • A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
    ModernaTX, Inc. · Completed · NCT06033261
  • A phase 3,randomised,double blind,active controlled study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease ckd …
    AstraZeneca Pharmaceuticals LP
  • A phase 3 placebocontrolled doubleblinded randomized study to evaluate the efficacy safety and tolerability of a clostridioides difficile vaccine in adults 65 years of age and older
    Pfizer Inc.
  • A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
    Teva Pharmaceuticals USA, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Internal Medicine clinicians in Lake City

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 21, 2011), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1578570727. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.